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Abstract
Background: Interstitial Cystitis (IC) is a chronic inflammatory condition of the bladder with unknown etiology. The
aim of this study was to characterize the microbial community present in the urine from IC female patients by 454
high throughput sequencing of the 16S variable regions V1V2 and V6. The taxonomical composition, richness and
diversity of the IC microbiota were determined and compared to the microbial profile of asymptomatic healthy
female (HF) urine.
Results: The composition and distribution of bacterial sequences differed between the urine microbiota of IC
patients and HFs. Reduced sequence richness and diversity were found in IC patient urine, and a significant
difference in the community structure of IC urine in relation to HF urine was observed. More than 90% of the
IC sequence reads were identified as belonging to the bacterial genus Lactobacillus, a marked increase compared to
60% in HF urine.
Conclusion: The 16S rDNA sequence data demonstrates a shift in the composition of the bacterial community in
IC urine. The reduced microbial diversity and richness is accompanied by a higher abundance of the bacterial
genus Lactobacillus, compared to HF urine. This study demonstrates that high throughput sequencing analysis of
urine microbiota in IC patients is a powerful tool towards a better understanding of this enigmatic disease.
Background
Interstitial Cystitis or Painful Bladder Syndrome (IC/
PBS) is a chronic condition characterized by frequent
urination and bladder pain, which often results in
reduced quality of life. Clinicians experience that this
disease is becoming more prevalent [1]. While evidence
suggests that about 90% of those affected are female,
some urologists consider chronic bacterial prostatitis to
be the male equivalent of IC.
The traditional definition of this illness is chronic ster-
ile bladder inflammation of unknown etiology and it has
not been possible to prove any causative pathogenic
agent for this syndrome [2,3]. Currently there are four
major hypotheses of pathogenesis: 1) autoimmunity, 2)
deficiency of the glycosaminoglycan layer causing
increased bladder wall permeability, 3) neurogenic in-
flammation and 4) chronic infection [4].
While several features of IC have suggested an infect-
ive etiology, numerous studies using traditional culture
techniques have failed to provide consistent evidence
that IC is associated with infection. It has been proposed
that possible microbial agents causing this disease could
be difficult to cultivate or are present in numbers too
low to be confirmed in the laboratory [5]. Advances in
molecular-based diagnostics have made it possible to
overcome the limitations of culture-based detection.
Investigators have used PCR, cloning and 16S ribosomal
DNA (rDNA) sequencing to search for pathogenic
agents in bladder biopsies and urine specimens of IC
patients [6-11], but with conflicting results. However,
some of these studies have indicated that women with
IC may have a higher prevalence of bacteria in the urine
than those without IC [6,8,9].
Furthermore, clinical studies have demonstrated that
administration of antibiotics may sometimes be corre-
lated with decreased symptoms in patients [12-14]. This
can be due to both inhibition of bacterial growth or as a
conventional anti-inflammatory effect of doxycycline. A
study by Zhang et al. (2010) [15] not only demonstrates
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improvement in symptoms, but also a decreased level of
nanobacteria after antibiotic treatment, strongly suggest-
ing a microbial association of IC in some cases.
We recently developed approaches to assess the major
microbial populations in female human urine, based on
16S rDNA PCR followed by 454 pyrosequencing and
analyses using a suite of bioinformatics tools (Siddiqui et al.
(2011) [16]. We have shown that healthy female (HF)
urine is a complex milieu with many different bacteria
present. The normal human urine microbiota includes
numerous fastidious and anaerobic microbes, which are
potentially pathogenic [16-19]. In this work we applied
these techniques in a prospective study to describe the
microbial community present in urine from IC patients.
We also performed a comparative analysis between the
IC sequence dataset and the HF dataset previously gen-
erated [16] to determine to what extent the bacterial
profiles differ. Our analyses indicate important differ-
ences between the two microbiota. We observe a lower
complexity and variation between urine from IC indivi-
duals in relation to HF individuals.
Methods
Urine sampling
This study was approved by the Regional Committee for
Medical Research Ethics East –Norway (REK st Pros-
jekt 110-08141c 1.2008.367), and the samples were taken
with informed consent. 8 female patients of age from 27
to 67 years (P1 = 59, P2 = 40, P3 = 27, P4 = 47, P5 = 31,
P6 = 35, P7 = 32, P8 = 67) underwent thorough clinical
examination including cystoscopy and fulfilled the cri-
teria of European Society for the Study of Interstitial
Cystitis (ESSIC) [20]. All patients had an established
diagnosis of IC for more than four years. Midstream
urine (30 ml) was collected by the clean catch method
with labial separation supervised by an urotherapy nurse.
Specimens were kept at 4°C, and within an hour
processed for DNA isolation. All specimens used were
culture-negative, as tested by the Urological Clinic at the
University Hospital HF Aker-Oslo. None of the patients
was receiving antibiotics at the time samples were taken,
nor prior to that according to hospital records.
Sample processing and DNA isolation
Sample processing and DNA extraction was performed
as previously described in Siddiqui et al. (2011) [16].
Briefly, urine aliquots (30 ml) were pelleted by centrifu-
gation and total DNA was isolated from sediments using
DNeasy Blood & Tissue kit (QIAGEN, Germany), pre-
ceded by incubation with POWERlyse (lysis buffer)
(NorDiag ASA, Oslo, Norway). Finally, the DNA was eluted
in 100 μl of AE buffer from the kit. The DNA concentra-
tions in the samples (P1-P8) were measured by Quant-iT
PicoGreeen dsDNA assay kit (Molecular Probes, Invitro-
gen USA) and ranged from 0.22 ng/μl to 4.36 ng/μl.
16S rDNA PCR and 454-pyrosequencing
For each IC urine sample, we amplified 16S rDNA
sequences using two different primer sets specific for
the V1V2 and V6 hypervariable regions followed by 454
pyrosequencing as described in Siddiqui et al. (2011)
[16]. Each of the primers consisted of a target specific
region at their 3’ end (V1V2 or V6) and an adapter se-
quence (Primer A or Primer B) at their 5’ end as needed
for GS FLX amplicon sequencing (454 Life Sciences,
USA). Equal amounts of the two different amplicons
(both V1V2- and V6-region) for a single subject were
pooled and sequenced using GS-FLX chemistry in the
same lane of a Pico-Titer plate divided into 16 lanes, ex-
cept for samples P1, P2 and, P3, for which each ampli-
con (V1V2 and V6) was sequenced in a separate lane.
454 pyrosequencing was performed by the Norwegian
Sequencing Centre (NSC) at the Department of Biology,
University of Oslo, Norway.
Sequence read preprocessing
Sequence read preprocessing was done as described in
Siddiqui et al. (2011) [16]. In brief, a total of 187,901
reads were produced from IC female urine samples. The
initial sequence reads were split into two pools using the
V1V2 and V6 primer sequences via the sfffile program
from 454 Life Sciences (Roche), thus reducing the
sequences to 172,931 IC urine reads (Table 1) due to the
program splitting on an exact primer match. With a
minimum length cutoff of 218 and 235 nt for the V1V2-
and V6-regions, respectively, the sequences were pro-
cessed through the Pyronoise program [21] to reduce
possible insertion/deletion errors at homopolymer runs.
After denoising using Pyronoise, one sequence per clus-
ter is retained together with the number of total reads
mapping to that cluster.
The bacterial identification technique of broad range
16S rDNA PCR is highly sensitive to environmental con-
tamination. To control for this the IC urine sample se-
quence sets were stripped for sequences that could stem
from contamination sources. This was done by using
contamination control sequences (total = 25,246) from
negative control extractions (buffer and kit reagents)
followed by PCR and pyrosequencing, as reported in
Siddiqui et al. (2011) [16]. A complete linkage clustering
at 1% genetic difference of each sample together with its
respective control was performed using ESPRIT (http://
www.biotech.ufl.edu/people/sun/esprit.html [22]). Any
sample sequences found in clusters where ≥ 50% of the
sequences belonged to the contamination control were
excluded from subsequent analyses (details in Siddiqui et
al. (2011) [16]).
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Sequence data generated in this study were submitted
to the Sequence Read Archive with the study accession
number ERP001705. The dataset is available at http://
www.ebi.ac.uk/ena/data/view/ERP001705.
Taxonomical analysis
For taxonomic grouping of the sequence reads, MEGAN
V3.4 http://www-ab.informatik.uni-tuebingen.de/software/
megan/welcome.html [23,24] was used. First, the sequence
reads were compared to a curated version of the SSUrdp
database [25] using blastn with a maximum expectation
value (E) of 10-5. To reflect the actual abundance behind
every denoised sequence cluster, each entry in the blast re-
sult file was replicated as many times as the total number
of reads that mapped to that query sequence (for detailed
procedure and parameters see Siddiqui et al. (2011) [16]).
When comparing the individual datasets using MEGAN,
numbers of reads were normalized up to 100,000 for every
dataset.
Metastats, statistical methods (http://metastats.cbcb.
umd.edu/, [26,27]) for detecting differentially abundant
taxa, was used to reveal significant differences between
IC urine microbiota and HF urine microbiota (taxonomy
assessed in Siddiqui et al. 2011 [16]). This method
employs a false discovery rate to improve specificity in
high-complexity environments, and in addition handles
sparsely sampled features using Fisher’s exact test. The
Metastats p - values at different taxon levels, which were
assigned using MEGAN, are listed in Additional file 1:
Table S1. A p - value ≤ 0.05 was considered significant.
Comparative OTU based clustering analysis of IC and HF
urine
Numbers of operational taxonomical units (OTUs),
rarefaction curves and diversity indices were calculated
using MOTHUR v1.22.2 [28,29] (see Table 1). To en-
able comparisons, the HF sequences generated in
Siddiqui et al. (2011) [16] were reanalyzed along with
Table 1 Sampling depth and biodiversity found by amplicon 454 pyrosequencing V1V2 and V6 region from urine
Combined sequence pool from HF urine1 Combined sequence pool from IC urine2
V1V2 V6 V1V2 V6
Preprocessing
Total reads 78346 74067 74211 98720
Length cutoff 3 48861 45382 46272 62325
Denoised4 48860 45136 46267 62173
Cleaned5 48452 44760 46138 62032
Taxonomy analysis
Phyla6 10 8 5 7
Genera6 35 28 23 25
OTU and Diversity indices
Cleaned5 48452 44760 46138 62032
Silva 16S alignment7 46001 44146 44594 61170
Unique OTUs 974 2045 514 1432
OTUs8 (3%) 724 1537 344 1008
OTUs8 (6%) 615 1265 292 786
Chao19 (3%) 1435 3936 357 2485
Chao1 LCI95 1261 3521 675 2172
Caho1 HCI95 1664 4437 1137 2883
Shannon index10 (3%) 2.62 3.02 1.67 1.95
Inverse Simpson index11 (3%) 6.97 7.03 3.57 3.72
1Combined sequence data from eight healthy female (HF) urine samples, sequences generated in prior study (Siddiqui et al. (2011) [16]).
2Combined sequence data from eight interstitial cystitis (IC) urine samples.
3Length cutoff at minimum 218 nt for V1V2 and 235 nt for V6 reads.
4Total number of sequences after processing the dataset through Pyronoise [21].
5The number of reads per dataset after removal of sequences that could be from the same source as those in the contamination control dataset as described in
Siddiqui et al. (2011) [16].
6Number of phyla and genera based on taxonomic classification by MEGAN V3.4 [23,24].
7The number of total reads after Silva 16S alignment as recommended by MOTHUR [29].
8OTUs: Operational Taxonomic Units at 3% or 6% nucleotide difference.
9Chao1 is an estimator of the minimum richness and is based on the number of rare OTUs (singletons and doublets) within a sample.
10The Shannon index combines estimates of richness (total number of OTUs) and evenness (relative abundance).
11Inverse Simpson index (1/D) is an indication of the richness a community with uniform evenness would have at the same level of diversity. It takes into account
the number of OTUs present, as well as the abundance of each OTU.
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the IC dataset from this study. Briefly, the sequences
were aligned to the Silva 16S alignment as recom-
mended by MOTHUR [29] – sequences not aligned or
aligned outside of where 95% of all of the sequences
aligned were removed from the datasets. For an
improved OTU clustering single linkage preclustering
[30] was performed, allowing two nucleotides to differ
between sequences, before clustering using average link-
age. The processing was done both on each separate
sample and on pooled V1V2 and V6 sequences for both
IC and HF samples. We also calculated the OTUs and
Shannon index for normalized numbers of sequences for
each separate sample [31]. A random number of reads,
corresponding to the lowest number of sequences in a
sample group, i.e. 2,720 for V1V2 and 2,988 for V6, was
picked 100 times from each sequence set. These new se-
quence sets were processed through MOTHUR in the
same fashion as the full sequence sets and the average
of the resulting OTUs and Shannon values are shown in
Additional file 2: Table S2.
The differences in Shannon indices and inverse Simpson
indices for the two communities (IC and HF urine) were
also statistically evaluated byWilcox rank sum test in R, for
both theV1V2 andV6amplicondatasets.
Venn diagrams were generated for both data sets using
MOTHUR to calculate how many OTUs were shared
between the two communities. To further explore the
relationships between the two microbial communities,
samples were clustered into Newick-formatted trees
(using the UPGMA algorithm) with distance between
communities calculated with θYC coefficient as a meas-
urement of dissimilarity between community structures
[32] in MOTHUR. In addition, weighted UniFrac testing
[33] was performed to determine the statistical signifi-
cance of clustering within the tree. A non-metric multi-
dimensional scaling (NMDS) plot was generated in R for
the distances calculated using θYC measures for each se-
quence dataset (V1V2 and V6), knowing that θYC
weighs rare and abundant OTUs more evenly than other
metrics such as Jaccard.
Results
454 pyrosequenced 16S rDNA amplicon sequences
After preprocessing of the raw IC 454 reads as described
in Siddiqui et al. (2011) [16], we obtained a total of 46,
138 and 62,032 16S rDNA sequences for V1V2 and V6
regions, respectively, see Table 1. For comparison pur-
poses, the preprocessing information for the HF urine
sequences reported in Siddiqui et al. (2011) [16] is also
listed in the table. Average number of reads per IC
sample was 5,767 and 7,754 for V1V2 and V6, respec-
tively (range: V1V2 3035–9506; V6 4900–14602) see
Additional file 2: Table S2. 97% of the preprocessed
sequences were classified to phylum, order and family
level, and 95% of the sequences were identified down to
genus level.
Composition of the IC urine microbiota
In total, 7 phyla were identified by the 16S rDNA
sequences when the two different amplicon libraries (i.e.
V1V2 and V6 16S regions) were considered together
(Figure 1A). 93% of the bacterial DNA sequences were
assigned to Firmicutes, while the other 7% were assigned
to 6 additional phyla. Actinobacteria was the second
major phylum with 5% of the sequence abundance. Bac-
teroidetes and Tenericutes were represented by 1% of
total bacterial sequences each, while three phyla – Pro-
teobacteria, Fusobacteria and Nitrospirae – were
detected by less than 1% of the assigned sequences.
In comparison to HF urine (Siddiqui et al. (2011)
[16]), IC urine has a significantly higher proportion of
Firmicutes (p ≤ 0.05, p value from Metastats for V1V2)
(65% vs 93%, respectively) and reduced proportions of
the other 5 common phyla (Figure 1A). Interestingly, the
phylum Nitrospirae was only detected in IC urine. Five
additional phyla present in HF urine (Siddiqui et al.
(2011) [16]) were not identified in IC urine at all
(Figure 1A). The distribution of major phyla in IC urine
was similar for both the V1V2 and V6 sequence dataset,
although Fusobacteria and Nitrospirae were only identi-
fied by the V6 sequence dataset.
Sequence reads for all phyla but one (Nitrospirae
0.003% of the reads) were further classified to order
level. 16 of the 22 orders identified in healthy urine
(Siddiqui et al. (2011) [16]) were also detected in IC
urine. A significant shift in the bacterial composition
was observed as a result of an increase of Lactobacillales
(Figure 1B and C) (p ≤ 0.05, p value from Metastats for
V1V2) in the IC urine microbial community relative to
HF urine. 92% and 91% of the reads for V1V2 and V6
respectively, were assigned to this order. In HF urine
only 53% of the reads for V1V2 and 55% for V6 were
assigned to Lactobacillales. The abundance of other
major orders seen in HF urine is reduced in IC samples
(Figure 1B and Additional file 1: Table S1).
All sequence reads assigned to the order level were
additionally assigned to family level. Among the 26 fam-
ilies identified, only 21 were assigned to different genera.
Four of those families that were not further assigned
(Pasteurelacae, Neisseriacae, Methyliphilaceae, and
Micrococcaceae) were also detected in the HF urine
study. Saprospiraceae, on the other hand was only found
in IC urine.
At the genus level, the pooled sequences were assigned
to 31 different genera, with 23 and 25 different genera
for V1V2 and V6 analysis, respectively. Lactobacillus
was the most abundant genus in both datasets and com-
prised a total of 92% of the sequences. Gardnerella and
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Corynebacterium were the two other major genera iden-
tified with 2% sequence abundance each. Prevotella and
Ureaplasma were each represented by 1% of the
sequences assigned. The other 26 genera determined in
IC urine constituted only 2% of the total IC urine bac-
terial community.
In contrast to HF urine, there was a considerable re-
duction in total numbers of genera identified in IC urine
(45 genera vs. 31 genera, respectively) (Additional file 1:
Table S1). Additionally, the abundance of common gen-
era was found to differ between IC patients and healthy
females. The significant increase of Lactobacillus
(p ≤ 0.05, p values from Metastats for both V1V2 and
V6) in IC urine compared to HF urine again suggested a
structural shift in the microbiota of IC patients. Entero-
coccus, Atopobium, Proteus and Cronobacter are 4 gen-
era identified in IC urine that were not detected in our
previous HF urine study, while a group of 17 genera
were only associated with HF urine.
Sequences from 16 of the genera identified in the IC
samples were further assigned to 22 different species
(Additional file 3: Table S3). When comparing to our
previous study, 13 of these species are already found in
asymptomatic HF urine. However, nine of these species
were not identified in our previous study, nor associated
with IC according to literature.
Variation between individual IC urine samples
A clustering analysis using taxonomical data from both
IC and HF individual urine samples is shown in Figure 2.
As previously demonstrated for HF urine (Siddiqui et al.
2011 [16]), variation between individuals was also evident
for IC urine samples and a polymicrobial state was iden-
tified for all but one of the IC urine specimens. Although
a clear clustering of samples from the two communities
(IC and HF) was not apparent, we observed a narrower
taxonomical range and reduced complexity in individual
IC urine samples compared to the results from individual
HF samples.
In all but two IC urine samples, Lactobacillus accounted
for more than ~95% of the sequences for both V1V2 and
V6 data. Lactobacillus was not only the most abundant
genus, but also the most frequent genus among all IC
urine specimens with its rRNA sequences present in all
eight samples, in contrast to urine samples from HF
(6/8). Sequences assigned to Prevotella, Peptoniphilus and
Anaerococcus were also frequently detected (5/8), followed
by Staphylococcus and Finegoldia (4/8), and Gardnerella,
Streptococcus and Dialister (3/8) in IC urine. Including
Ureaplasma, 7 genera were identified by reads belonging
to 2 urine samples and another 15 genera were only
detected in 1 out of the 8 samples.
Species richness and diversity
Estimation of species richness and diversity were calcu-
lated for the two combined V1V2 and V6 sequence pools
(Table 1), as well as for single urine samples (Additional
file 2: Table S2). At the species level, defined as OTUs at
3% genetic difference, 344 species for the V1V2 and 1,008
species for the V6 sequence datasets were estimated in
IC FEMALE URINE
HEALTHY FEMALE URINE
A   Phylum   
C    Order       V6
B   Order       V1V2
HF
HF
  IC
  IC
Figure 1 Summary of the microbial phyla and orders detected in interstitial cystitis urine and healthy female urine. A: A comparative
taxonomic tree view of 16S rDNA sequences from interstitial cystitis (IC) urine and healthy female (HF) urine assigned to the phylum level as
computed using MEGAN V3.4. Normalized counts by pooling together results from V1V2 and V6 16S rDNA sequence datasets were used for both
IC and HF urine. B and C: Comparison of taxonomic assignments for IC and HF urine sequences at the order level, showing an increase of the
order Lactobacillales in IC urine sequences relative to HF urine, for both V1V2 (B) and V6 datasets (C).
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the IC urine community. At a more conservative level,
defined as OTUs at 6% dissimilarity level, 292 and 786
OTUs were estimated for V1V2 and V6, respectively.
These numbers for richness are considerably lower than
found in HF urine (Table 1 and Figure 3A). The number
of OTUs at 3% difference for the individual samples for
both IC and HF are indicated in box plots (Figure 3B) for
both V1V2 and V6 analysis. In general, fewer number of
OTU clusters were observed for IC individuals than that
for HF individuals. Ecological diversity measured by
Shannon and inverse Simpson indices also indicate lower
diversity in IC urine in comparison to what was seen in
urine from HF (Figure 3C and D). Specifically, a signifi-
cant (p< 0.05) decrease in inverse Simpson index in IC
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Figure 2 Hierarchical clustering of urine microbiomes. Heat map showing the relative abundance of bacterial genera across the urine
samples. Genera are listed to the right. Subjects are listed at the top: interstitial cystitis (IC) samples denoted as P_number_V1V2 or V6, and
healthy female (HF) urine samples as F_number_V1V2 or V6. Pink indicates IC urine, green HF urine. Color intensity of the heat map is directly
proportional to log 10 scale of the abundance normalized sequence data as done by MEGAN V3.4. Taxa marked with (*) are genera that were
significantly (p≤ 0.05, p value from Metastats) different between the IC and HF urine microbiota. Genera marked with (†) and (}) are unique for
HF urine sequences and IC urine sequences, respectively. Note that most of the IC urine samples are less complex than what is seen for HF urine
samples.
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patients compared to HF was found for the V6 analysis.
Taken together, the results for both V1V2 and V6 support
each other and confirm that the urine community is less
diverse in IC patients than in HF individuals. However,
the single IC outlier with high richness and diversity
(Figure 3B-D) also clustered outside the IC group in the
clustering analysis done using taxonomy data (Figure 2)
showing that there is also potential for variation within
the IC community.
The IC and HF urine also showed a degree of commu-
nity similarity at 3% sequence dissimilarity level - about
12% and 9.5% of the total OTUs for V1V2 and V6, re-
spectively, were present in both groups (Additional file
4: Figure S1). To further explore the relationships be-
tween the two communities, θYC distances, taking into
account both community association and relative
abundance, were calculated at 3% dissimilarity level for
all samples. These distances for both V1V2 and V6 data-
sets were then visualized by NMDS plots; see Figure 4A
and B. Although an overlap between the two communi-
ties is detected, HF urine samples were more dispersed
than IC samples. A pattern of less variation between
samples from IC patients than for HF samples was sug-
gested. Weighted UniFrac hypothesis testing for θYC
distances confirmed the significance (p < 0.001) of the
differences observed in the community structure.
Discussion
We have characterized the urine microbiota of IC patients
using high throughput 454 pyrosesequencing of 16S
rDNA amplicons. These results were compared to HF
data from our previous study (Siddiqui et al. (2011) [16]).
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Figure 3 Comparison of richness and diversity estimations of urine from interstitial cystitis (IC) patients and healthy females (HF).
A: Rarefaction curves depicting number of OTUs (at 3% genetic difference) as function of the total number of sequences for the combined
sequence pool datasets for IC urine V1V2 and V6 (red and orange) and HF urine V1V2 and V6 (dark and light blue). The curves show a decreased
estimate of species richness in the IC urine microbiome compared to the HF urine microbiome. B, C, and D: Box plots showing richness and
diversity of 16S rDNA sequences. Boxes contain 50% of the data and have lines at the lower quartile (red), median and upper quartile (green)
values. Ends of the whiskers mark the lowest and highest value. The plots show the results of a combined assessment of the eight urine samples
in each HF and IC microbiome and with normalized numbers of sequences for OTU and Shannon index values (B and C). B: Observed OTU
counts (at 3% genetic difference) of all urine samples taken from HF and IC, for both V1V2 and V6 datasets. C and D: Shannon index and inverse
Simpson index at 3% sequence dissimilarity calculated to estimate diversity for both V1V2 and V6 datasets. Asterisks (*) indicate significant
differences (Wilcox rank sum test: * p< 0.05). Note that a single sample (P2) in the IC community is the only outlier with the highest values for
both richness and diversity (for both V1V2 and V6 analysis).
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Figure 4 OTU based clustering analysis of urine microbiomes. Non-metric multidimensional scaling (NMDS) plots were generated based on θYC
distances (0.03) between interstitial cystitis (IC) and healthy female (HF) microbiomes for both V1V2 (A) and V6 region (B). Red: IC patient samples; blue: HF samples.
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Our results did not reveal any single potential patho-
genic bacterium common to all IC patients. However,
important differences were detected between the IC and
HF microbiota.
The use of primers for both V1V2 and V6 regions
yielded complementary results for IC urine in line with
the previous study of HF urine (Siddiqui et al. (2011)
[16]), and thus maximized the detection of bacterial
diversity.
Knowing that urine samples are at risk of contamin-
ation by bacterial flora of the female urogential system
[34,35], mid-stream urine sampling was performed under
guidance of an experienced urotherapy nurse. Suprapu-
bic puncture was suggested as an alternative method, but
the method was considered to be too invasive. Interest-
ingly, comparing results from our previous microbiome
study on female mid-stream urine (Siddiqui et al. 2011)
[16] with recent results from suprapubic aspirate by
Wolfe et al. (2012) [19], the major findings are the same;
a strong indication that mid-stream urine will give com-
parable results in a urine microbiome analysis.
A decrease in species richness in IC urine
A decrease in overall richness and ecological diversity (as
indicated by rarefaction analysis, number of OTUs,
Shannon index and inverse Simpson index estimations) of
IC urine microbiota was detected in contrast to HF urine
(Table 1 and Figure 3). In addition, the ß-diversity analysis
(θYC distances between all urine samples) suggested that
the microbiota of HF samples are more dissimilar from
each other than the microbiota of IC individuals.
The taxonomical analysis indicated a shift in compos-
ition of urine microbiota of IC patients, with changes in
bacterial groups spanning from genus to phyla level and a
reduction in microbial complexity compared to HF. More
importantly, a significant increase in Lactobacillus in IC
patients was revealed. Lactobacillus was detected in every
IC urine sample and a total sequence abundance of 92% in
contrast to 57% in HF urine was observed. This shift was
also clearly displayed both at the order and phylum level
(Lactobacillales and Firmicutes, respectively). In contrast,
Prevotella, - a genus belonging to the phylum Bacteroi-
detes (order Bacteriodales) – was present only at 1%, sig-
nificantly lower than in HF urine, where it was previously
reported as one of the major genera with an abundance of
19%. Gardnerella, another dominant genus in female
urine, was present with the same frequency in IC urine
but with a general lower abundance.
A reduction in bacterial diversity and shift in the
microbiota as observed in this chronic inflammatory
state has also been reported for other clinical conditions
such as obesity, irritable bowel syndrome, and inflamma-
tory bowel disease including Crohn’s disease [36-38].
Bacteria associated with IC
Attempts to identify an infectious etiology for IC have
not yet found any evidence for a specific pathogen.
However, previous culture-dependent studies of samples
from IC patients (i.e. bladder biopsy, midstream urine)
have reported organisms such as Gardnerella, Lactoba-
cillus sp., Streptococcus ssp., Escherichia coli, Proteus
mirabilis, Corynebacterium ssp., Klebsiella sp., Entero-
coccus sp., Propionbacterium, Prevotella, Bacteroides sp.,
and Peptostreptococcus [6,9,39]. Lactobacillus, Gardner-
ella and Streptococcus were repeatedly detected in these
studies and were also seen in our study. Haarala et al.
(1999) [9] using culture techniques concluded that bac-
terial flora of midstream urine from patients with IC
clearly differs from that of healthy women, in line with
our findings. A study by Zhang et al. (2010) [15] sug-
gested nanobacteria as a possible causative agent for IC.
The two latter studies also reported a reduction in bac-
terial levels and urinary symptoms upon antibiotic treat-
ment of the IC patients. The primer pairs both for V1V2
and V6 amplicons used in our study would be expected
to amplify 16S rDNA regions of all of the organisms
mentioned above. Nevertheless we did not identify
Klebsiella, E.coli, Peptostreptococcus or nanobacteria
in any of our IC urine samples.
Studies reporting results from culture-independent
16S rDNA PCR approaches on samples (i.e. bladder bi-
opsy, midstream urine) from IC patients, have yielded
somewhat conflicting results both in terms of positive
PCRs and the resulting bacterial profiles [7,8,10,11,40].
While two of the reports [11,40] found no evidence of
bacterial DNA in biopsy and urine specimens from IC
patients, Dominique et al. (1995) [8] demonstrated bac-
terial DNA in bladder tissues in 29% of patients with IC.
The 4 sequences retrieved showed homology to E. coli
(2) and Pseudomonas (2), however neither of these bac-
teria was found in our study. Heritz et al. (1997) [10]
also reported bacterial DNA in both biopsies and urines
from IC patients (53% and 46%, respectively). They con-
cluded that there is a difference in the bacterial profile
between the patients and controls, and further suggested
a link between one or more bacterial species and IC.
However, in their study only 11 bacterial clones from 3
different IC patients were analyzed and the bacterial
sequences were related to E.coli, Abiotrophia defectivus,
Veillonella and Rothia dentocariosa. Except for Veillo-
nella, these bacteria were not detected in our study. All
these 4 previously reported studies used different primer
sets (likely to explain some of the differences in the
results) and classical cloning strategies (explaining the
very few sequences analyzed). In contrast, our study
represents the first 16S rDNA amplicon high throughput
sequencing approach on IC urine, increasing both the
sensitivity and resolution of the investigation.
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Significance of Lactobacillus in IC urine
Lactobacillus has not only been indicated or shown in
IC urine samples from females (100% of the cases in this
study and as shown by others [6,9,39]) but also demon-
strated in IC urine from a male subject [41]. In our
study we also detected a significant increase in abun-
dance of this genus, considering its supposedly com-
mensal presence in human urine from healthy subjects
[16,18,19].
Lactobacillus is generally considered to be of low viru-
lence, rarely causing infections in humans. It is best
known for its presence in vaginal microflora, where it
normally generates and maintains a physiological acidic
environment, which prevents infections. Because of
these properties, Lactobacillus has been used in probio-
tics, and is thought to prevent or even treat urinary tract
infection (UTI) [42]. However, there are increasing indi-
cations that specific Lactobacillus spp are of pathogenic
relevance and may be involved in urinary tract infections
[43,44].
Many female patients with symptoms suggestive of UTI,
but with culture-negative urines are often treated with
antibacterial agents since their symptoms may be indistin-
guishable from those with a proven UTI [45]. It has been
proposed that Lactobacillus, resistant to widely used anti-
biotics, may multiply during treatment, giving the genus
an advantage over antibiotic-sensitive commensals, and
allowing it to invade the proximal urethra and paraure-
thral tissues causing inflammatory changes [45]. This or-
ganism has also been related to the presence of UTI
symptoms in otherwise culture-negative urines [43,44,46].
In a study by Maskell et al. (1983) [46] antibacterial treat-
ment was withheld over the course of 2 years from symp-
tomatic women with culture-negative urine. During the
course of the study Lactobacilli (detected by special cul-
ture techniques) gradually disappeared from the urine
of most of the patients who also became symptom free.
A similar association of Lactobacillus and urinary symp-
toms was reported by Darbro et al. (2009) [44]. Over a
six-month period a female patient had constant
symptoms and high counts of Lactobacillus spp
(> 50,000 CFU/ml) in the urine; she became symptom-
free with culture-negative urine after treatment with
Lactobacillus-targeted medication. These results also
suggest that a shift in the microbial community towards
Lactobacillus in IC urine samples may be an important
etiological factor for the severe symptoms reported by
the patients. Since additional culture techniques such as
48 h incubation in an atmosphere containing 7% CO2
are needed for detection of Lactobacillus, this may be
the reason why IC urine samples have not yet been asso-
ciated with bacterial growth in routine clinical investiga-
tions. However, in our study this problem was overcome
by a culture-independent approach.
Conclusion
This investigation did not reveal any obvious putative
causative bacterial agents of IC. However, the greater
abundance of Lactobacillus in IC urine and its lower oc-
currence in HF urine is an important finding that
requires further study to establish whether these micro-
bial changes play a part in the development of IC. To
this end, whole genome sequencing of Lactobacillus
from IC patients may be a possible approach. Even if an
increased presence of Lactobacillus is merely a second-
ary marker, understanding its IC associated genomics
could aid in diagnosis and therapeutic assessment.
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